VHL and neoplasm: This recommendation was based on literature reports that have calculated that patients with an apparently isolated VHL-related tumor and no detectable VHL mutation have a risk of ≈ 5% of developing subsequent VHL-related tumors within 10 years of the diagnosis of their first tumor [28].